AAISG 2016 Annual Meeting

Buford, GA US
April 29, 2016 to May 1, 2016

The purpose of this program is to enhance the knowledge base of participants so that they, in turn, can provide the most up-to-date treatments for patients under their care.  We want to provide this information in a way that encourages questions and interaction among participants to deliver a thorough understanding of the areas of allergy, asthma & immunology.

Target Audience

Practitioners in the field of allergy, asthma & immunology

Learning Objectives

At the conclusion of the program, participants should be able to:

  • Demonstrate knowledge in the field of allergy.
  • Collaborate and interact with experts in their field.
  • Promote networking amongst participants to enhance or modify current practices.
  • Promote better patient care by learning new methods of treatment for the patient population.
  • Encourage physicians to share ideas and concerns for areas in which they feel further educational training is necessary.
Additional information
Disclosure: 

AAISG 2016 Annual Meeting
Buford, Georgia
April 29 – May 1, 2016

Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

^ Mark Boguniewicz, MD -- Speaker
   Anacor—Research Grant
   Regeneron—Consultant
   Celgene—Advisory Board

^ Luz Fonacier, MD – Speaker 
   Genentech – Research and Educational Grants: (Made to Winthrop University Hospital)
   Merck – Research and Educational Grants: (Made to Winthrop University Hospital)
   Baxter – Speaker’s Bureau/Honoraria – Consultant 
   Church and Dwight, Co., Inc

^ Dennis Ledford, MD – Speaker 
   Astra Zeneca – Consultant/Advisory Board/Speaker/Research Grant
   Boehringer-Ingelheim – Consultant/Advisory Board/Speaker
   Genentech – Consultant/Advisory Board/Speaker/Research Grant
   Circassia – Speaker/Research Grant
   Merck – Speaker
   Meda – Speaker
   Novartis – Speaker
   Teva – Speaker
   Wilkes, Smith, O’Hara, McCoy, Ford & Wilkes – Legal Review (drug allergy, anaphylaxis, latex allergy)

^ Robert Chrzanowski, MD – Staff, AAISG Treasurer
   Astra Zeneca – Speaker, Research Grant
   Teva – Speaker
    Merck – Speaker 

The following have no relevant financial relationships to disclose

Thomas Chacko, MD- Staff, AAISG President
Dean Firschein, MD—Staff, AAISG Secretary
Leslie Morris – Staff, AASIG Administrator
Michelle Barron, MD – Speaker
Lindsay Still, MD – Speaker
Laura Green, MD – Speaker
Jeffrey Franklin, MD – Speaker
Anu Mallapaty, MD – Speaker
Renata Engler, MD – Speaker 


Education Staff has no relevant financial relationships to disclose.

Kathleen Sheerin, MD—AAISG Vice President--Program Chair and Physician Planner

Course summary
Available credit: 
  • 8.25 AMA PRA Category 1 Credit™
  • 8.25 Attendance
Course opens: 
04/27/2016
Course expires: 
05/01/2018
Event starts: 
04/29/2016 - 7:00pm
Event ends: 
05/01/2016 - 11:55am
Cost:
$0.00
Rating: 
3
Legacy Lodge Conference Center
7000 Lanier Islands Parkway
Buford, GA 30518
United States

Available Credit

  • 8.25 AMA PRA Category 1 Credit™
  • 8.25 Attendance

Accreditation Period

Course opens: 
04/27/2016
Course expires: 
05/01/2018

Price

Cost:
$0.00
Please login or create an account to take this course.